CO60 Predicting Treatment Effects from Surrogate Endpoints in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Abstract
Authors
I. Samjoo T. Disher E. Castro J. Ellis S. Paganelli J. Nazari A. Niyazov